[Transfusional independence in a patient with refractory anemia with excess blasts-2 refractory to 5-azacitidine treated with deferasirox and colony stimulating factors]

MeSH terms

• Aged
• Anemia, Refractory, with Excess of Blasts / drug therapy*
• Anemia, Refractory, with Excess of Blasts / therapy
• Azacitidine / pharmacology*
• Azacitidine / therapeutic use
• Benzoates / administration & dosage
• Benzoates / therapeutic use*
• Blood Transfusion*
• Chelation Therapy*
• Combined Modality Therapy
• Deferasirox
• Disease Progression
• Drug Resistance
• Epoetin Alfa
• Erythropoietin / administration & dosage
• Erythropoietin / therapeutic use*
• Fatal Outcome
• Granulocyte Colony-Stimulating Factor / administration & dosage
• Granulocyte Colony-Stimulating Factor / therapeutic use*
• Humans
• Iron Chelating Agents / administration & dosage
• Iron Chelating Agents / therapeutic use*
• Iron*
• Leukemia, Myeloid, Acute
• Male
• Recombinant Proteins / administration & dosage
• Recombinant Proteins / therapeutic use
• Triazoles / administration & dosage
• Triazoles / therapeutic use*